Is a complete BST/29TA research report available?

No complete published report is available for bst/29TA (BST/29TA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/29TA (BST/29TA)

Stuttgart Stock Exchange: BST/29TA · EUR

€1.56

-0.02 (-1.3%)· Recorded snapshot

Market cap	18.5M
Revenue (ttm)	2.9M
Net income (ttm)	-189.9K
EPS (ttm)	-€0.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.9M
Net income (ttm): -189.9K
EPS (ttm): -€0.02
Market cap: 18.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-12
Employees	1
Employees change	0
Employees growth	0%
Enterprise value	EUR 15.2M
Exchange	Stuttgart Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2008
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US88338N2062
Last refreshed	2026-10-28
Market cap	EUR 18.5M
Next earnings date	2026-11-12
Price	EUR 1.56
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bst/29TA
Website	https://www.therapeuticsmd.com

Metric

Value

Amount currency

EUR

Country

United States

Country code

Earnings date

2026-11-12

Employees

Employees change

Employees growth

Enterprise value

EUR 15.2M

Exchange

Stuttgart Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-10-10

Fiscal year end

December

Founded

2008

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

ISIN number

US88338N2062

Last refreshed

2026-10-28

Market cap

EUR 18.5M

Next earnings date

2026-11-12

Price

EUR 1.56

Price currency

EUR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bst/29TA

Website

https://www.therapeuticsmd.com

Metric	Value
Earnings yield	-1.33%
EV/FCF	5.43x
EV/Sales	5.19x
FCF / EV yield	18.41%
FCF yield	15.17%
Industry forward P/E	17.38x
Industry P/E	28.22x
P/(FCF - SBC) ratio	6.72x
P/(OCF - SBC) ratio	6.72x
P/B ratio	0.78x
P/FCF ratio	6.59x
P/OCF ratio	6.59x
P/S ratio	6.46x
Price / tangible book value	0.9x
Sector forward P/E	14.8x
Sector P/E	39.91x

Metric

Value

Earnings yield

-1.33%

EV/FCF

5.43x

EV/Sales

5.19x

FCF / EV yield

18.41%

FCF yield

15.17%

Industry forward P/E

17.38x

Industry P/E

28.22x

P/(FCF - SBC) ratio

6.72x

P/(OCF - SBC) ratio

6.72x

P/B ratio

0.78x

P/FCF ratio

6.59x

P/OCF ratio

6.59x

P/S ratio

6.46x

Price / tangible book value

0.9x

Sector forward P/E

14.8x

Sector P/E

39.91x

Metric	Value
EBIT margin	-53.55%
EBITDA margin	-41.87%
FCF margin	95.41%
Gross margin	100%
Operating margin	-53.55%
Pretax margin	-8.04%
Profit margin	-6.64%
Profit per employee	EUR -189,940
Profitable quarters	2
Revenue per employee	EUR 2.9M
ROA	-2.88%
ROA (5Y)	-7.5%
ROCE	-5.38%
ROE	-1.08%
ROIC	-7.31%
SBC / revenue	1.74%
Tax / revenue	0.98%

Metric

Value

EBIT margin

-53.55%

EBITDA margin

-41.87%

FCF margin

95.41%

Gross margin

100%

Operating margin

-53.55%

Pretax margin

-8.04%

Profit margin

-6.64%

Profit per employee

EUR -189,940

Profitable quarters

Revenue per employee

EUR 2.9M

ROA

-2.88%

ROA (5Y)

-7.5%

ROCE

-5.38%

ROE

-1.08%

ROIC

-7.31%

SBC / revenue

1.74%

Tax / revenue

0.98%

Metric	Value
EPS growth (Q)	-80.62%
EPS growth (QoQ)	12.41%
EPS growth years	2
FCF growth	272.76%
FCF growth (Q)	137.65%
FCF growth (QoQ)	-17.74%
Gross profit growth	27.78%
Gross profit growth (Q)	-8.72%
Gross profit growth 3Y	-63.88%
Gross profit growth 5Y	-45.35%
Net income growth (Q)	-71.87%
Net income growth (QoQ)	63.16%
Net income growth years	2
OCF growth	272.76%
OCF growth (Q)	137.65%
OCF growth (QoQ)	-17.74%
Revenue growth	27.78%
Revenue growth (Q)	-8.72%
Revenue growth (QoQ)	20.03%
Revenue growth 10Y	-16.63%
Revenue growth 3Y	-63.95%
Revenue growth 5Y	-47.85%
Revenue growth years	2

Metric

Value

EPS growth (Q)

-80.62%

EPS growth (QoQ)

12.41%

EPS growth years

FCF growth

272.76%

FCF growth (Q)

137.65%

FCF growth (QoQ)

-17.74%

Gross profit growth

27.78%

Gross profit growth (Q)

-8.72%

Gross profit growth 3Y

-63.88%

Gross profit growth 5Y

-45.35%

Net income growth (Q)

-71.87%

Net income growth (QoQ)

63.16%

Net income growth years

OCF growth

272.76%

OCF growth (Q)

137.65%

OCF growth (QoQ)

-17.74%

Revenue growth

27.78%

Revenue growth (Q)

-8.72%

Revenue growth (QoQ)

20.03%

Revenue growth 10Y

-16.63%

Revenue growth 3Y

-63.95%

Revenue growth 5Y

-47.85%

Revenue growth years

Metric	Value
Depreciation and amortization	EUR 343,401
EBIT	EUR -1.5M
EBITDA	EUR -1.2M
EPS	EUR -0.02
Free cash flow	EUR 2.8M
Free cash flow minus SBC	EUR 2.8M
Gross profit	EUR 2.9M
Income taxes	EUR 28,010
Net cash flow	EUR 2.7M
Net income	EUR -189,940
Operating cash flow minus SBC	EUR 2.8M
Operating income	EUR -1.5M
Revenue	EUR 2.9M
Stock-based compensation	EUR 49,892

Metric

Value

Depreciation and amortization

EUR 343,401

EBIT

EUR -1.5M

EBITDA

EUR -1.2M

EPS

EUR -0.02

Free cash flow

EUR 2.8M

Free cash flow minus SBC

EUR 2.8M

Gross profit

EUR 2.9M

Income taxes

EUR 28,010

Net cash flow

EUR 2.7M

Net income

EUR -189,940

Operating cash flow minus SBC

EUR 2.8M

Operating income

EUR -1.5M

Revenue

EUR 2.9M

Stock-based compensation

EUR 49,892

Metric	Value
Altman Z-Score	-34.09
Book value per share	EUR 2.05
Debt / equity	0.2
Debt / FCF	1.74
Long-term assets	EUR 18.4M
Long-term liabilities	EUR 4.6M
Net cash (debt)	EUR 3.2M
Net cash / market cap	17.18%
Net debt / equity	-0.13
Net debt / FCF	-1.13
Piotroski F-Score	4
Property, plant and equipment	EUR 4.3M
Shareholders' equity	EUR 23.7M
Tangible book value	EUR 20.6M
Tangible book value per share	EUR 1.78
Total assets	EUR 32.8M
Total cash	EUR 8M
Total debt	EUR 4.9M
Total liabilities	EUR 9.1M

Metric

Value

Altman Z-Score

-34.09

Book value per share

EUR 2.05

Debt / equity

0.2

Debt / FCF

1.74

Long-term assets

EUR 18.4M

Long-term liabilities

EUR 4.6M

Net cash (debt)

EUR 3.2M

Net cash / market cap

17.18%

Net debt / equity

-0.13

Net debt / FCF

-1.13

Piotroski F-Score

Property, plant and equipment

EUR 4.3M

Shareholders' equity

EUR 23.7M

Tangible book value

EUR 20.6M

Tangible book value per share

EUR 1.78

Total assets

EUR 32.8M

Total cash

EUR 8M

Total debt

EUR 4.9M

Total liabilities

EUR 9.1M

Metric	Value
Asset turnover	0.09
Current assets	EUR 14.5M
Current liabilities	EUR 4.5M
Current ratio	3.22
Net working capital	EUR 2.6M
Quick ratio	2.65
Working capital	EUR 9.7M
Working capital turnover	0.29

Metric

Value

Asset turnover

0.09

Current assets

EUR 14.5M

Current liabilities

EUR 4.5M

Current ratio

3.22

Net working capital

EUR 2.6M

Quick ratio

2.65

Working capital

EUR 9.7M

Working capital turnover

0.29

Metric	Value
Buyback yield / dilution	-0.23%
Shareholder yield	-0.23%

Metric

Value

Buyback yield / dilution

-0.23%

Shareholder yield

-0.23%

Metric	Value
150-day SMA	EUR 1.74
1D price change	-1.27%
1M price change	-11.36%
1M total return	-11.36%
1W price change	-4.29%
1W total return	-4.29%
1Y price change	60%
1Y return CAGR	60.05%
1Y total return	60%
20-day SMA	EUR 1.68
200-day SMA	EUR 1.79
3M price change	-12.36%
3M total return	-12.36%
3Y price change	-16.58%
3Y return CAGR	-5.86%
3Y total return	-16.58%
50-day SMA	EUR 1.76
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 2.40
52-week high date	2026-01-27
52-week low	EUR 1.12
52-week low date	2025-11-19
6M price change	-11.86%
6M total return	-11.86%
All-time high	EUR 11.20
All-time high date	2022-08-15
All-time low	EUR 0.79
All-time low date	2025-03-04
Average true range (ATR)	EUR 0.07
Average volume	0
Change from 52-week high	-35%
Change from 52-week low	39.29%
Change from all-time high	-86.07%
Change from all-time low	97.47%
Change from open	1.96%
Day's gap	-3.16%
High price	EUR 1.56
Low price	EUR 1.52
Monthly RSI	40.93
Open price	EUR 1.53
Position in 52-week range	100%
Previous close	EUR 1.58
Price vs 150-day SMA	-10.4%
Price vs 20-day SMA	-7.36%
Price vs 200-day SMA	-12.8%
Price vs 50-day SMA	-11.56%
RSI	31.65
Sharpe ratio	0.75
Sortino ratio	1.33
Weekly RSI	40.37
YTD price change	12.23%
YTD total return	12.23%

Metric

Value

150-day SMA

EUR 1.74

1D price change

-1.27%

1M price change

-11.36%

1M total return

-11.36%

1W price change

-4.29%

1W total return

-4.29%

1Y price change

60%

1Y return CAGR

60.05%

1Y total return

60%

20-day SMA

EUR 1.68

200-day SMA

EUR 1.79

3M price change

-12.36%

3M total return

-12.36%

3Y price change

-16.58%

3Y return CAGR

-5.86%

3Y total return

-16.58%

50-day SMA

EUR 1.76

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 2.40

52-week high date

2026-01-27

52-week low

EUR 1.12

52-week low date

2025-11-19

6M price change

-11.86%

6M total return

-11.86%

All-time high

EUR 11.20

All-time high date

2022-08-15

All-time low

EUR 0.79

All-time low date

2025-03-04

Average true range (ATR)

EUR 0.07

Average volume

Change from 52-week high

-35%

Change from 52-week low

39.29%

Change from all-time high

-86.07%

Change from all-time low

97.47%

Change from open

1.96%

Day's gap

-3.16%

High price

EUR 1.56

Low price

EUR 1.52

Monthly RSI

40.93

Open price

EUR 1.53

Position in 52-week range

100%

Previous close

EUR 1.58

Price vs 150-day SMA

-10.4%

Price vs 20-day SMA

-7.36%

Price vs 200-day SMA

-12.8%

Price vs 50-day SMA

-11.56%

RSI

31.65

Sharpe ratio

0.75

Sortino ratio

1.33

Weekly RSI

40.37

YTD price change

12.23%

YTD total return

12.23%

Metric	Value
Float	9.5M
Shares change (QoQ)	0.03%
Shares change (YoY)	0.23%
Shares held by insiders	2.2%
Shares held by institutions	22.72%
Short ratio	1 days

Metric

Value

Float

9.5M

Shares change (QoQ)

0.03%

Shares change (YoY)

0.23%

Shares held by insiders

2.2%

Shares held by institutions

22.72%

Short ratio

1 days

BST/29TA (BST/29TA)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/29TA

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/29TA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/29TA

Frequently asked questions